Pazopanib (Standard)

Overview

Pazopanib (Standard) is the analytical standard of Pazopanib. This product is intended for research and analytical applications. Pazopanib (GW786034) is a novel multi-target inhibitor of VEGFR1 , VEGFR2 , VEGFR3 , PDGFRβ , c-Kit , FGFR1 , and c-Fms with IC 50 s of 10, 30, 47, 84, 74, 140 and 146 nM, respectively.

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Others | Products > Signaling Pathways > Autophagy | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > FGFR | Products > Signaling Pathways > Reference Standards | Products > Signaling Pathways > VEGFR | Products > Signaling Pathways > c-Kit | Products > Signaling Pathways > PDGFR | Products > Signaling Pathways > Autophagy

Product Information

• Catalog No.: HY-10208R
• CAS No.: 444731-52-6
• Molecular Formula: C21H23N7O2S
• Molecular Weight: 437.52
• Purity: 98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Availability: In-stock

Source

Original product source